This article is more than 5 years old. Information may no longer be current.

OSN’s top news of the week

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Here are some top stories on Healio.com/OSN from the past week:

Iluvien approved for new indication in UK

The United Kingdom has added a new indication for Iluvien, approving it for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye. Read more.

Novartis completes Alcon spin-off

Shares of Alcon, the world’s largest eye care device company, began trading Tuesday on the SIX Swiss Exchange and the New York Stock Exchange under the symbol ALC. Read more.

TearSolutions completes $6.4 million financing

TearSolutions has completed $6.4 million in financing to complete a pivotal FDA phase 2 clinical trial of its lead product candidate Lacripep. Read more.

Full-thickness corneal transplants with cataract surgery still have a role

The corneal triple procedure, either combined or staged, has undergone significant evolution in the past several decades. Read more.

Surgeon offers pearls on using toric lenses in keratoconus cases

Toric IOLs can be a viable option in patients with astigmatism and keratoconus. Read more.